News

Amgen price target raised to $319 from $315 at UBS
UBS raised the firm’s price target on Amgen (AMGN) to $319 from $315 and keeps a Neutral rating on the shares. The firm is expecting an in-line ...
Swiss bank lobby steps up warnings on UBS relocation risk
Switzerland's main banking lobby on Friday said the Swiss economy could face serious consequences if UBS were driven away, ...
UBS hires Evan Raine as head of media and telecom M&A for Americas
UBS Group has hired Evan Raine to head its media and telecoms mergers and acquisitions unit in the Americas to help the bank ...
Time For Your Annual Wellness Checkup…. Your Financial Wellness
An annual financial checkup is a proactive step toward achieving and maintaining financial health. By systematically ...
UBS shareholders back 2024 compensation report with 86.7% of votes
In an advisory vote, UBS shareholders on Thursday backed the bank's 2024 compensation report with 86.7% of votes, compared to 83.5% for the same report a year earlier. CEO Sergio Ermotti's total pay ...
Pfizer price target lowered to $24 from $28 at UBS
UBS analyst Trung Huynh lowered the firm’s price target on Pfizer (PFE) to $24 from $28 and keeps a Neutral rating on the shares. The firm says ...